Carbocisteina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Carbocisteina" in Italian language version.

refsWebsite

Global rank Italian rank

14nih.gov

4^th place

9^th place

4oadoi.org

799^th place

22^nd place

4doi.org

2^nd place

7^th place

1chemspider.com

8,573^rd place

low place

1archive.org

6^th place

8^th place

archive.org

CN. Berry, KG. Lloyd; P. Louisot, Effects of S-carboxymethyl-L-cysteine on pulmonary sialyl transferase activity in vitro, in healthy and in sulphur-dioxide-induced bronchitic rats., in Fundam Clin Pharmacol, vol. 6, n. 1, 1992, pp. 29-35, PMID 1555809.

chemspider.com

CSID:168055, https://www.chemspider.com/Chemical-Structure.168055.html (accessed 08:52, Dec 31, 2012)

doi.org

dx.doi.org

A. Macciò, C. Madeddu; F. Panzone; G. Mantovani, Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases., in Expert Opin Pharmacother, vol. 10, n. 4, marzo 2009, pp. 693-703, DOI:10.1517/14656560902758343, PMID 19239402.
M. Decramer, W. Janssens, Mucoactive therapy in COPD., in Eur Respir Rev, vol. 19, n. 116, giugno 2010, pp. 134-40, DOI:10.1183/09059180.00003610, PMID 20956182.
P. Poole, PN. Black, Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease., in Cochrane Database Syst Rev, n. 2, 2010, pp. CD001287, DOI:10.1002/14651858.CD001287.pub3, PMID 20166060.
YC. Duijvestijn, N. Mourdi; J. Smucny; G. Pons; M. Chalumeau, Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003124, DOI:10.1002/14651858.CD003124.pub3, PMID 19160217.

nih.gov

ncbi.nlm.nih.gov

G. Lamblin, P. Humbert; P. Degand; P. Roussel, [Heterogeneity of carbohydrate chains of acidic bronchial mucin isolated from the spatum of two subjects with chronic bronchitis]., in Clin Chim Acta, vol. 79, n. 2, settembre 1977, pp. 425-36, PMID 890979.
CN. Berry, KG. Lloyd; P. Louisot, Effects of S-carboxymethyl-L-cysteine on pulmonary sialyl transferase activity in vitro, in healthy and in sulphur-dioxide-induced bronchitic rats., in Fundam Clin Pharmacol, vol. 6, n. 1, 1992, pp. 29-35, PMID 1555809.
L. Brandolini, M. Allegretti; V. Berdini; MN. Cervellera; P. Mascagni; M. Rinaldi; G. Melillo; P. Ghezzi; M. Mengozzi; R. Bertini, Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs)., in Eur Cytokine Netw, vol. 14, n. 1, Gen-Mar 2003, pp. 20-6, PMID 12799210.
JP. Bébéar, V. Calas; B. Lablache Combier, [Carbocysteine in catarrhal ORL diseases]., in Rev Laryngol Otol Rhinol (Bord), vol. 111, n. 5, 1990, pp. 499-501, PMID 2087616.
JM. Polu, E. Puchelle; P. Sadoul, [Bronchial expectorants : pharmacology of bronchial mucomodifiers]., in Sem Hop, vol. 60, n. 9, febbraio 1984, pp. 643-58, PMID 6324374.
DT. Brown, Carbocysteine., in Drug Intell Clin Pharm, vol. 22, n. 7-8, Lug-Ago 1988, pp. 603-8, PMID 3046890.
PC. Braga, L. Allegra; C. Rampoldi; A. Ornaghi; G. Beghi, Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis., in Respiration, vol. 57, n. 6, 1990, pp. 353-8, PMID 2099568.
A. Macciò, C. Madeddu; F. Panzone; G. Mantovani, Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases., in Expert Opin Pharmacother, vol. 10, n. 4, marzo 2009, pp. 693-703, DOI:10.1517/14656560902758343, PMID 19239402.
M. Decramer, W. Janssens, Mucoactive therapy in COPD., in Eur Respir Rev, vol. 19, n. 116, giugno 2010, pp. 134-40, DOI:10.1183/09059180.00003610, PMID 20956182.
P. Poole, PN. Black, Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease., in Cochrane Database Syst Rev, n. 2, 2010, pp. CD001287, DOI:10.1002/14651858.CD001287.pub3, PMID 20166060.
G. Hillas, S. Nikolakopoulou; S. Hussain; T. Vassilakopoulos, Antioxidants and Mucolytics in COPD Management: When (if ever) and in Whom?, in Curr Drug Targets, vol. 14, n. 2, febbraio 2013, pp. 225-34, PMID 23256719.
YC. Duijvestijn, N. Mourdi; J. Smucny; G. Pons; M. Chalumeau, Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003124, DOI:10.1002/14651858.CD003124.pub3, PMID 19160217.
Carbocisteine: frequent cutaneous adverse effects., in Prescrire Int, vol. 16, n. 87, febbraio 2007, p. 17, PMID 17326276.
JL. Schmutz, A. Barbaud; P. Trechot, [Fixed drug eruption and carbocysteine]., in Ann Dermatol Venereol, vol. 132, n. 4, aprile 2005, p. 403, PMID 15886580.

oadoi.org

A. Macciò, C. Madeddu; F. Panzone; G. Mantovani, Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases., in Expert Opin Pharmacother, vol. 10, n. 4, marzo 2009, pp. 693-703, DOI:10.1517/14656560902758343, PMID 19239402.
M. Decramer, W. Janssens, Mucoactive therapy in COPD., in Eur Respir Rev, vol. 19, n. 116, giugno 2010, pp. 134-40, DOI:10.1183/09059180.00003610, PMID 20956182.
P. Poole, PN. Black, Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease., in Cochrane Database Syst Rev, n. 2, 2010, pp. CD001287, DOI:10.1002/14651858.CD001287.pub3, PMID 20166060.
YC. Duijvestijn, N. Mourdi; J. Smucny; G. Pons; M. Chalumeau, Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease., in Cochrane Database Syst Rev, n. 1, 2009, pp. CD003124, DOI:10.1002/14651858.CD003124.pub3, PMID 19160217.